A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer
This is a multi-centre real-world non-interventional observational study. The study data on patient demographic/tumor biological characteristics and clinical treatments were retrospectively collected to evaluate effectiveness of sublobar dissection in the Chinese patients with non-small cell lung cancer who received sublobar dissection.
Study Type
OBSERVATIONAL
Enrollment
3,902
Sublobar dissection plus lymphadenectomy
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
China PLA General Hospital
Beijing, Beijing Municipality, China
Henan cancer hospital
Zhengzhou, Henan, China
Overall survival
Overall survival
Time frame: 2014 - 2017
Overall survivals in subgroups
Overall survivals categorised by tumor biological characteristics
Time frame: 2014 - 2017
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China
Jiangsu cancer hospital
Nanjing, Jiangsu, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Huaxi Hospital Affiliated to Sichuan University
Chengdu, Sichuan, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, China